• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估先进混合闭环 (AHCL) 在儿童和青少年中使用的时间紧范围 (TITR) 目标的可行性:一项单中心真实世界研究。

Assessing the feasibility of time in tight range (TITR) targets with advanced hybrid closed loop (AHCL) use in children and adolescents: A single-centre real-world study.

机构信息

Division of Pediatric Endocrinology and Diabetes, Koc University Hospital, Istanbul, Turkey.

Koc University School of Medicine, Istanbul, Turkey.

出版信息

Diabet Med. 2024 Aug;41(8):e15333. doi: 10.1111/dme.15333. Epub 2024 Apr 26.

DOI:10.1111/dme.15333
PMID:38671595
Abstract

AIMS

Time in Tight Range (TITR) is a novel glycaemic metric in monitoring type 1 diabetes (T1D) management. The aim of this study was to assess the attainability of the TITR target in children and adolescents using the advanced hybrid closed loop (AHCL).

METHODS

The 2128-day CGM data from 56 children and adolescents with T1D using AHCL (Minimed-780G) were analysed. Time in Range (TIR) (3.9-10 mmol/L), TITR (3.9-7.7 mmol/L), and other glycaemic parameters were separately analysed in terms of whole day, daytime (06.00-23:59), and nighttime (00.00-05.59) results. The participants were divided into two groups by autocorrection rate where Group 1 had a rate of <30% and Group 2 had a rate of ≥30.

RESULTS

All glycaemic parameters indicated a better glycaemic outcome in the nighttime with higher TIR and TITR values compared with daytime (for TIR 87.5 ± 9.5% vs. 78.8 ± 8%, p < 0.001, and TITR 68.2 ± 13.5% vs. 57.5 ± 8.8%, p < 0.001). The rates of TITR >50% and >60% were 87% and 52%, respectively. When those with TITR >60% (n: 29) and those without (n: 27) were evaluated in terms of hypoglycaemia, no statistically significant difference was found in time below range (TBR) 3-3.9 mmol/L (0.3% vs. 2.1%, p: 0.084) and TBR < 3 mmol/L (0.47% vs. 0.3%, p: 0.298). Group 1 had a significantly higher TIR and TITR compared to Group 2 (82.6 ± 6.1% vs. 75.6 ± 8.6%, p: 0.008 and 62.1 ± 7.5% vs. 53.8 ± 7.5%, p: 0.002, respectively).

CONCLUSIONS

Most children and adolescents on AHCL achieved the 50% target for TITR whereas more than half achieved the >60% target. A target of >50% for TITR seems realistic in children with T1D using AHCL.

摘要

目的

时间在紧凑范围内(TITR)是监测 1 型糖尿病(T1D)管理的一种新的血糖指标。本研究旨在使用先进的混合闭环(AHCL)评估儿童和青少年达到 TITR 目标的可能性。

方法

对 56 名使用 AHCL(Minimed-780G)的 T1D 儿童和青少年的 2128 天连续血糖监测(CGM)数据进行分析。分别分析全天、白天(06:00-23:59)和夜间(00:00-05:59)的血糖参数,包括血糖在目标范围内时间(TIR)(3.9-10mmol/L)、TITR(3.9-7.7mmol/L)和其他血糖参数。根据自动校正率将参与者分为两组,其中组 1 的校正率<30%,组 2 的校正率≥30%。

结果

所有血糖参数均表明夜间的血糖控制更好,TIR 和 TITR 值更高,与白天相比(TIR 为 87.5±9.5%比 78.8±8%,p<0.001,TITR 为 68.2±13.5%比 57.5±8.8%,p<0.001)。TITR>50%和>60%的比例分别为 87%和 52%。当评估 TITR>60%(n=29)和 TITR≤60%(n=27)的患者的低血糖情况时,血糖在目标范围内时间(TBR)3-3.9mmol/L(0.3%比 2.1%,p=0.084)和 TBR<3mmol/L(0.47%比 0.3%,p=0.298)之间无统计学差异。与组 2 相比,组 1 的 TIR 和 TITR 明显更高(82.6±6.1%比 75.6±8.6%,p=0.008 和 62.1±7.5%比 53.8±7.5%,p=0.002)。

结论

大多数接受 AHCL 的儿童和青少年达到了 TITR 50%的目标,而超过一半的患者达到了>60%的目标。对于使用 AHCL 的 T1D 儿童,TITR>50%的目标似乎是现实的。

相似文献

1
Assessing the feasibility of time in tight range (TITR) targets with advanced hybrid closed loop (AHCL) use in children and adolescents: A single-centre real-world study.评估先进混合闭环 (AHCL) 在儿童和青少年中使用的时间紧范围 (TITR) 目标的可行性:一项单中心真实世界研究。
Diabet Med. 2024 Aug;41(8):e15333. doi: 10.1111/dme.15333. Epub 2024 Apr 26.
2
Utility of time in tight range (TITR) in evaluating metabolic control in pediatric and adult patients with type 1 diabetes in treatment with advanced hybrid closed-loop systems.时间在紧密范围内(TITR)在评估使用先进混合闭环系统治疗的 1 型糖尿病儿科和成年患者代谢控制中的作用。
Endocrine. 2024 Nov;86(2):539-545. doi: 10.1007/s12020-024-03881-6. Epub 2024 May 30.
3
Time In Tight Range in children and adolescents with type 1 diabetes: A cross-sectional observational single centre study evaluating efficacy of new advanced technologies.1 型糖尿病患儿和青少年的时间在狭窄范围内:一项评估新型先进技术疗效的横断面观察性单中心研究。
Diabetes Metab Res Rev. 2024 Jul;40(5):e3826. doi: 10.1002/dmrr.3826.
4
Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial.比较 1 型糖尿病孕妇的先进混合闭环治疗与标准胰岛素治疗(CRISTAL):一项平行组、开放标签、随机对照试验。
Lancet Diabetes Endocrinol. 2024 Jun;12(6):390-403. doi: 10.1016/S2213-8587(24)00089-5. Epub 2024 Apr 30.
5
12-Month Real-Life Efficacy of the MiniMed 780G Advanced Closed-Loop System in Patients Living with Type 1 Diabetes: A French Observational, Retrospective, Multicentric Study.12 个月迷你美敦力 780G 高级闭环系统治疗 1 型糖尿病患者的真实世界疗效:一项法国观察性、回顾性、多中心研究。
Diabetes Technol Ther. 2024 Jun;26(6):426-432. doi: 10.1089/dia.2023.0414. Epub 2024 Feb 7.
6
The psychosocial outcomes of advanced hybrid closed-loop system in children and adolescents with type 1 diabetes.青少年 1 型糖尿病患者使用先进混合闭环系统的心理社会结果。
Eur J Pediatr. 2024 Jul;183(7):3095-3103. doi: 10.1007/s00431-024-05551-1. Epub 2024 Apr 25.
7
During an 18-month course of automated insulin delivery treatment, children aged 2 to 6 years achieve and maintain a higher time in tight range.在 18 个月的自动胰岛素输送治疗期间,2 至 6 岁儿童达到并维持更高的时间在严格范围内。
Diabetes Obes Metab. 2024 Jun;26(6):2431-2438. doi: 10.1111/dom.15562. Epub 2024 Mar 21.
8
Safety and Glycemic Outcomes During the MiniMed Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 Diabetes.安全性和血糖控制效果:MiniMed 先进型混合闭环系统在儿童和青少年 1 型糖尿病患者中的关键性试验
Diabetes Technol Ther. 2023 Nov;25(11):755-764. doi: 10.1089/dia.2023.0255. Epub 2023 Oct 25.
9
Evaluation of time in tight range and the glycaemia risk index in adults with type 1 diabetes using an advanced hybrid closed loop system: A 1-year real-world assessment.使用先进的混合闭环系统评估 1 型糖尿病成人的血糖时间在窄范围内的情况和血糖风险指数:一项为期 1 年的真实世界评估。
Diabetes Obes Metab. 2024 Sep;26(9):4078-4086. doi: 10.1111/dom.15766. Epub 2024 Jul 15.
10
Predictors of time in target glucose range in real-world users of the MiniMed 780G system.真实世界中使用 MiniMed 780G 系统的患者目标血糖范围内时间的预测因素。
Diabetes Obes Metab. 2022 Nov;24(11):2212-2221. doi: 10.1111/dom.14807. Epub 2022 Aug 1.

引用本文的文献

1
Real-world evaluation of safety and efficacy of AHCL systems in young children with type 1 diabetes: a 1-year assessment.1型糖尿病幼儿AHCL系统安全性和有效性的真实世界评估:为期1年的评估
Front Endocrinol (Lausanne). 2025 Jun 26;16:1590964. doi: 10.3389/fendo.2025.1590964. eCollection 2025.
2
Moving the Goalposts: Do Adults With Type 1 Diabetes Want Time in Tight Range?改变目标:1型糖尿病成年人希望血糖严格达标吗?
Endocr Pract. 2025 Apr 18. doi: 10.1016/j.eprac.2025.03.006.
3
Harnessing Machine Learning, a Subset of Artificial Intelligence, for Early Detection and Diagnosis of Type 1 Diabetes: A Systematic Review.
利用机器学习(人工智能的一个子集)进行1型糖尿病的早期检测与诊断:一项系统评价
Int J Mol Sci. 2025 Apr 22;26(9):3935. doi: 10.3390/ijms26093935.
4
The Relationship Between Glycated Albumin and Time in Tight Range in Type 2 Diabetes.2型糖尿病中糖化白蛋白与严格血糖控制时间的关系
J Diabetes. 2025 Mar;17(3):e70073. doi: 10.1111/1753-0407.70073.
5
Long-term use of Minimed™ 780G in children and adolescents with type 1 diabetes under real-world conditions: The benefits of optimal settings.在现实环境中,1型糖尿病儿童和青少年长期使用美敦力™780G:优化设置的益处。
Diabetes Obes Metab. 2025 Apr;27(4):2309-2312. doi: 10.1111/dom.16226. Epub 2025 Jan 31.
6
Enhanced Metabolic Control in a Pediatric Population with Type 1 Diabetes Mellitus Using Hybrid Closed-Loop and Predictive Low-Glucose Suspend Insulin Pump Treatments.使用混合闭环和预测性低血糖暂停胰岛素泵治疗改善1型糖尿病儿科患者的代谢控制
Pediatr Rep. 2024 Dec 14;16(4):1188-1199. doi: 10.3390/pediatric16040100.
7
What is the Relationship Between Time in Range, Time in Tight Range, and HbA1c in Youth and Young Adults With Type 1 Diabetes? Results From the German/Austrian/Luxembourgian/Swiss Diabetes Prospective Follow-Up Registry.1型糖尿病青少年和青年的血糖达标时间、严格血糖达标时间与糖化血红蛋白之间有何关系?来自德国/奥地利/卢森堡/瑞士糖尿病前瞻性随访登记处的结果。
J Diabetes Sci Technol. 2024 Nov 16:19322968241288870. doi: 10.1177/19322968241288870.
8
Guidelines of the Polish Society of Pediatric Endocrinology and Diabetology and Pediatric Section of Diabetes Poland on insulin therapy using hybrid closed-loop systems in children and adolescents with diabetes in Poland.波兰儿科内分泌学和糖尿病学会以及波兰糖尿病儿科分会关于在波兰使用混合闭环系统为儿童和青少年糖尿病患者进行胰岛素治疗的指南。
Pediatr Endocrinol Diabetes Metab. 2024;30(3):132-147. doi: 10.5114/pedm.2024.144041.
9
Children and adolescent with suboptimal control of type 1 diabetes improve during the first 2 years on automated insulin delivery system.1型糖尿病控制不佳的儿童和青少年在使用自动胰岛素输送系统的头两年里病情有所改善。
Diabetes Obes Metab. 2025 Jan;27(1):134-142. doi: 10.1111/dom.15992. Epub 2024 Sep 30.
10
Exploring the Continuous Glucose Monitoring in Pediatric Diabetes: Current Practices, Innovative Metrics, and Future Implications.探索儿童糖尿病的持续葡萄糖监测:当前实践、创新指标及未来影响
Children (Basel). 2024 Jul 27;11(8):907. doi: 10.3390/children11080907.